White Lion GBM Innovation Fund

White Lion GBM Innovation Fund is a specialized biotechnology entity and investment vehicle focused on the development and commercialization of innovative therapies for Glioblastoma Multiforme (GBM). The fund operates by identifying high-potential research and early-stage assets specifically targeting the aggressive brain cancer, providing the necessary capital and strategic oversight to advance these programs through the development pipeline. Its primary mission is to bridge the gap between academic discovery and clinical application for GBM treatments. By concentrating resources on a single, high-unmet-need indication, the fund aims to accelerate the delivery of next-generation small molecules and immunotherapies to patients.